Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurochem Int ; 47(7): 482-90, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16135390

RESUMO

Superfused rat cerebral cortex slices were submitted to a continuous electrical (5 Hz) stimulation and treated with sodium azide (1-10 mM) in the presence of 2 mM 2-deoxyglucose ("chemical ischemia"). Presynaptic cholinergic activity, evaluated as acetylcholine release, was inhibited depending on the sodium azide concentrations and on the length of application (5-30 min). Following a 5-min treatment with 10 mM sodium azide, acetylcholine release was reduced to 45+/-2.3%; simultaneously, there was a 15- and 10-fold increase in glutamate and nitric oxide effluxes, respectively. After restoring normal superfusion conditions, acetylcholine release recovered to 70+/-3.1% of the controls; the N-methyl-D-aspartate receptor antagonist MK-801 (10 microM) as well as the nitric oxide scavengers, haemoglobin (20 microM) and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-l-oxyl-3-oxide (150 microM), improved the recovery in presynaptic activity, showing that both glutamate and nitric oxide play detrimental roles in chemical ischemia. On the other hand, the post-ischemic recovery was worsened by the guanylylcyclase inhibitor 1H-[l,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (10 microM), suggesting that the activation of such a pathway plays a neuroprotective role and that the nitric oxide-induced harmful effects depend on different mechanisms. Chemical ischemia-evoked nitric oxide efflux partly derived from its calcium-dependent endogenous synthesis, since both the intracellular calcium chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (1 mM), and the nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine methyl ester (100 microM), substantially prevented sodium azide effects. Nitric oxide efflux was only weakly reduced by MK-801 and was not modified by either the L-type calcium channel blocker, nifedipine (10 microM) or the N-type calcium channel blocker omega-conotoxin (0.5 microM), thus suggesting a prevailing intracellular calcium-dependence of nitric oxide production, although a partial extracellular calcium source cannot be ruled out. These findings show that sodium azide plus 2-deoxyglucose treatment is a useful protocol to induce brain ischemia in vitro and underline the involvement of nitric oxide in the complex events following the ischemic insult.


Assuntos
Isquemia Encefálica/induzido quimicamente , Isquemia Encefálica/metabolismo , Óxido Nítrico/metabolismo , Acetilcolina/metabolismo , Animais , Antimetabólitos/farmacologia , Catalase/metabolismo , GMP Cíclico/fisiologia , Desoxiglucose/farmacologia , Metabolismo Energético/efeitos dos fármacos , Ácido Glutâmico/metabolismo , Guanilato Ciclase/metabolismo , Técnicas In Vitro , Masculino , Óxido Nítrico Sintase/metabolismo , Ratos , Ratos Sprague-Dawley , Azida Sódica/metabolismo , Azida Sódica/farmacologia , Vasodilatadores/farmacologia
2.
Neurochem Int ; 42(1): 87-92, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12441172

RESUMO

The effect of cholecystokinin tetrapeptide (CCK(4)) and of different anxiolytic drugs on GABA outflow from the cerebral cortex was investigated in freely moving rats, by using the epidural cup technique. CCK(4) (3-30 microg/kg, i.p.) increased GABA outflow and induced objective signs of anxiety. These neurochemical and behavioral responses were prevented by the CCK(B) antagonist GV150013 at 0.1 microg/kg (i.p.). At higher doses (up to 30 microg/kg) this compound per se reduced GABA release and caused sedation, suggesting the presence of a CCKergic positive tonic modulation on GABA interneurons. Similarly the GABA(A) receptors modulator, diazepam (2mg/kg, i.p.) and the 5-HT(1A) agonist buspirone (3mg/kg, i.p.) reduced GABA outflow and caused the expected behavioral effects (reduced muscle tone, mild 5-HT syndrome) which were prevented by the respective, selective antagonists, flumazenil (1mg/kg, i.p.) and NAN-190 (3mg/kg, i.p.). These findings support the idea that GV150013, diazepam and buspirone inhibit GABAergic cortical activity, through the respective receptors. This neurochemical effect may represent the end-effect of various anxiolytic compounds affecting the cortical circuitry.


Assuntos
Adamantano/análogos & derivados , Ansiolíticos/farmacologia , Córtex Cerebral/efeitos dos fármacos , Tetragastrina/farmacologia , Ácido gama-Aminobutírico/metabolismo , Adamantano/antagonistas & inibidores , Adamantano/farmacologia , Animais , Buspirona/antagonistas & inibidores , Buspirona/farmacologia , Córtex Cerebral/metabolismo , Diazepam/farmacologia , Espaço Epidural , Feminino , Flumazenil/farmacologia , Hipnóticos e Sedativos/farmacologia , Masculino , Atividade Motora/efeitos dos fármacos , Relaxantes Musculares Centrais/farmacologia , Proteínas do Tecido Nervoso/efeitos dos fármacos , Compostos de Fenilureia/antagonistas & inibidores , Compostos de Fenilureia/farmacologia , Piperazinas/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/efeitos dos fármacos , Receptores de Serotonina/efeitos dos fármacos , Receptores 5-HT1 de Serotonina , Serotonina/metabolismo , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia
3.
Brain Res ; 922(1): 104-11, 2001 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-11730707

RESUMO

The outflow of [(3)H]5-hydroxytryptamine ([(3)H]5-HT) from electrically stimulated rat cortical slices was measured to ascertain the modulatory role of endogenous cholecystokinin (CCK) on the amine outflow and to test the hypothesis that different anxiolytic compounds inhibit 5-HT secretion. The [(3)H]5-HT outflow evoked at 10 Hz was increased up to +30% by CCK(4) 300-1000 nM, the effect being prevented by the CCK(B) receptor antagonist GV 150013, 3 nM. The limited sensitivity to CCK(4) seemed to depend on 5-HT auto-receptor feedback because pre-treatment with 100 nM methiothepin enhanced the [(3)H]5-HT outflow and lowered the CCK(4) threshold concentration from 300 to 30 nM. In addition, pre-treatment with 1 microM bacitracin to inhibit CCK metabolism increased [(3)H]5-HT efflux. This effect was concentration-dependently counteracted by GV150013 suggesting the presence of an endogenous CCK positive modulation. GV150013 30 nM, the 5-HT(1A) partial agonist buspirone 300 nM and the GABA(A) receptor modulator diazepam 10 nM, known to have anxiolytic properties, all significantly reduced the [(3)H] amine outflow from cortical slices by about 20%. This inhibition depended on their interaction with their respective receptors, which seemed to restrain the activity of functionally interconnected glutamatergic interneurones. In fact, APV (50 microM) and NBQX (10 microM) prevented the effect of the anxiolytic compounds. Thus, anxiolytic drugs with different receptor targets can reduce 5-HT outflow by dampening the glutamatergic signal, and in turn, the secretory process of the serotonergic nerve ending.


Assuntos
Adamantano/análogos & derivados , Ansiolíticos/farmacologia , Córtex Cerebral/metabolismo , Serotonina/metabolismo , Tetragastrina/farmacologia , Adamantano/farmacologia , Animais , Ansiolíticos/antagonistas & inibidores , Buspirona/farmacologia , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/fisiologia , Diazepam/antagonistas & inibidores , Diazepam/farmacologia , Estimulação Elétrica , Feminino , Moduladores GABAérgicos/antagonistas & inibidores , Moduladores GABAérgicos/farmacologia , Ácido Glutâmico/fisiologia , Técnicas In Vitro , Masculino , Compostos de Fenilureia/farmacologia , Núcleos da Rafe/citologia , Núcleos da Rafe/efeitos dos fármacos , Núcleos da Rafe/fisiologia , Ratos , Receptores de GABA-A/efeitos dos fármacos , Agonistas do Receptor de Serotonina/farmacologia , Tetragastrina/antagonistas & inibidores
4.
Bioorg Med Chem Lett ; 11(6): 823-7, 2001 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-11277529

RESUMO

6-Methoxylated and 8-oxygenated benztropines were prepared and evaluated for their DAT and SERT activity (binding and uptake inhibition). Methoxylation at the two-carbon bridge of benztropine produced a novel class of potent and selective DAT ligands. An interesting enantioselectivity was also observed for this new class of chiral benztropines. The inactivity of the 8-oxygenated analogues seems to point out that, unlike cocaine and its analogues, interactions of benztropine ligands with DAT may be strongly governed by the nitrogen atom.


Assuntos
Benzotropina/farmacologia , Proteínas de Transporte/metabolismo , Glicoproteínas de Membrana , Proteínas de Membrana Transportadoras , Antagonistas Muscarínicos/farmacologia , Proteínas do Tecido Nervoso , Benzotropina/química , Proteínas de Transporte/efeitos dos fármacos , Proteínas da Membrana Plasmática de Transporte de Dopamina , Ligantes , Conformação Molecular , Antagonistas Muscarínicos/química , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA